Type 1 diabetes (T1D) is an autoimmune condition that results in destruction of insulin-producing β cells in the pancreatic islets, thereby leaving affected patients dependent on exogenous insulin therapy (Bluestone et al, 2010). This evidence concerns the gene INS and type 1 diabetes mellitus.